Navigation Links
NanoLogix Adds Noted Journalist Bill Scanlon to Provide Media Relations
Date:3/23/2009

HUBBARD, Ohio, March 23 /PRNewswire-FirstCall/ -- NanoLogix announces that veteran journalist Bill Scanlon has joined the company to coordinate publicity in advance of major news. Scanlon's addition to the staff marks a significant evolution in the company's information flow to investors and media, and will aid in the introduction of the public to NanoLogix products.

Bill Scanlon brings 25 years of experience in science, medical and business writing to NanoLogix, including articles about rapid bio-detection. For the past 18 years, he worked at the Rocky Mountain News, until its closing last month. Among his numerous journalism honors are awards for articles about particle physics, politics, ultra-athletics, and medical transplants. His series on a hospital cover-up recently won the Associated Press's annual First Amendment Award.

Bret T. Barnhizer, CEO stated: "We are fortunate to have obtained Bill Scanlon's services. His addition comes at a time when key elements of our business plan are converging. Enhanced public relations will bring awareness of the capabilities of our BNP(TM) test kit technology as we move the company from pure R&D and into production."

About NanoLogix

NanoLogix is a biotechnology company focused primarily on medical diagnostics. Its products offer accelerated detection and identification of microorganisms present in infectious and non-infectious human diseases, such as tuberculosis, NTM, pneumonia, HIV/AIDS, cancer, cystic fibrosis, anthrax, and plague. In addition to medical and homeland security applications, NanoLogix technology is applicable in pharmaceutical, industrial, veterinary and environmental testing.

Patents granted to NanoLogix can be used in the areas of applied microbiology, soil microbiology and bioremediation, microbial physiology, molecular biology, pharmacology, pharmaco-kinetics, antibiotic sensitivity, stem-cell research, and bioreactor-based hydrogen generation."

More information on NanoLogix is available at: www.nanologixinc.com

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of NanoLogix, Inc., and members of its management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

    Contact:
    Investor Relations
    Carol Surrena
    Telephone: 330-534-0800
    E-mail: Carol@nanologixinc.com


'/>"/>
SOURCE NanoLogix
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. NanoLogix Inc. Appoints Two New Directors and Provides Operations Update
2. NanoLogix Inc. Announces Joint Development With CL Solutions and First Sales of Rapid Detection Kits
3. NanoLogix Inc. to Present at The American Society for Microbiology (ASM) General Meeting in Boston; Announces Product Line and Provides Operations Update
4. NanoLogix Inc. Provides Financial Update, Appoints Bert Pharis as New Director
5. NanoLogix Inc. Presents at the National Hydrogen Association Conference & Provides Operations, Management and Director Update
6. National Public Radio (NPR) Features Broadcast Articles on NanoLogix Hydrogen Bioreactor Operation at Welchs Foods
7. NanoLogixs Hydrogen-From-Waste Technology at Welchs Foods Featured on Environmental Radio Program
8. NanoLogix, Inc. Makes Stock Pick List
9. NanoLogix Inc. Sets Date for Annual Shareholder Meeting and Provides Shareholder Update
10. NanoLogix Inc. to Present at EBW Expo & Conference 2007
11. NanoLogix Inc. Announces Historical First in Energy Generation With Bioreactor-Produced Hydrogen at Welchs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... 24, 2017 Intralytix, Inc. announced that it ... a French family group. This investment marks the beginning ... and commercialize bacteriophage-based products, for various benefits in human ... As a global ... and markets innovative solutions for baking, food taste & ...
(Date:7/24/2017)... FL (PRWEB) , ... July ... ... Strategic Analyst, Kenny Soulstring, today announced that the stock market news outlet ... in risk assessment diagnostic testing that screens and identifies exposure, progression and ...
(Date:7/20/2017)... ... July 20, 2017 , ... Resoundant, Inc. is ... imaging centers around the U.S. that offer MR Elastography for liver fibrosis staging. ... needle biopsy for staging liver fibrosis assessment. , “MRE:connect was created in response ...
(Date:7/20/2017)... ... July 20, 2017 , ... Litmus Health ... announced its full advisory board. The board comprises leaders spanning business, technology, academia, ... PhD, former VP of Engineering, to Chief Technology Officer. Crooks will lead strategy ...
Breaking Biology Technology:
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/27/2017)... 2017  Catholic Health Services (CHS) has been ... (HIMSS) Analytics for achieving Stage 6 on the ... In addition, CHS previously earned a place in ... electronic medical record (EMR). "HIMSS Analytics ... EMR usage in an outpatient setting.  This recognition ...
(Date:3/23/2017)... Research and Markets has announced the addition of the ... Forecast to 2025" report to their offering. ... The Global Vehicle Anti-Theft System ... over the next decade to reach approximately $14.21 billion by 2025. ... forecasts for all the given segments on global as well as ...
Breaking Biology News(10 mins):